| OKE |
Report |
Adjusted EBITDA |
BEAT |
pred ~$2.120B vs. cons $2.091B |
MEDIUM |
| OKE |
Report |
NGL fractionation volume |
BEAT |
pred ~945 MBbl/d vs. cons 934.6 MBbl/d |
MEDIUM |
| OKE |
Report |
Natural-gas pipeline volume |
IN-LINE |
pred ~7.55 TBtu/d vs. cons 7.504 TBtu/d |
MEDIUM |
| OKE |
Guide |
Adjusted EBITDA (FY26) |
LOWER |
guide ~$8.25B midpoint vs. cons $8.361B |
MEDIUM |
| OKE |
Guide |
Waha-to-Katy optimization commentary (2H26) |
LOWER |
guide ~normalization vs. no formal consensus; 3Q EBITDA cons $2.105B |
LOW |
| OKE |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.5% |
— |
LOW |
| OKE |
Return |
5-day cumulative residual |
-4.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — implicit 4Q EBITDA cut should drive revisions |
LOW |